Sell this medical testing stock poised to fall more than 15% from here, Citi says in downgrade
It’s time for investors to sell shares of Quest Diagnostics , according to Citi. Analyst Patrick Donnelly downgraded shares of the medical testing company to sell from neutral, citing risks…